Analyst Ratings for Valeant Pharmaceuticals (vrx)

vrx Rating Summary

vrx Price Target Summary

* Over Last 12-Mos
  |   Expand Research on vrx
Overall Rating: BUY   Rating Trend: Down   Avg. $ Target: $134.60 (+10.8%) * Over Last 12-Mos
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
3/27/2014 Cantor Fitzgerald New Coverage Buy
(N/A)
200.00
(N/A)
129.07 121.45 -5.9% Details
1/8/2014 TD Securities Downgrade Hold
(Buy)
135.00
(N/A)
125.35 121.45 -3.11% Details
Like VRX Ratings? Also take a look at ACT, WCRX, ANAC, MYL

VRX Ratings News